News
WuXi STA to Purchase Bristol Myers Squibb Manufacturing Facility in Couvet, Switzerland
Bristol Myers Squibb and WuXi STA – a subsidiary of WuXi AppTec – announced that WuXi STA has agreed to purchase Bristol Myers Squibb’s manufacturing facility in Couvet, Switzerland. The Couvet site will be the first facility in Europe...
News
eClinical Solutions Launches elluminate Clinical Trial Management System for Faster Drug Development
eClinical Solutions LLC, a global provider of cloud-based enterprise software and software-driven clinical data services, announced the launch of the elluminate® Clinical Trial Management System (CTMS). Built on the elluminate platform, which accelerates digitization and reduces clinical data review...
Clinical Trials
Ampio Announces Early Positive Data in Phase 1 Trial of Inhaled Ampion in COVID-19 Respiratory Distress
Ampio Pharmaceuticals, Inc., a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, announced early positive data from its ongoing U.S. Phase I controlled, observer-blinded clinical trial of inhaled Ampion versus standard of care for...
News
Novartis to support Pfizer-BioNTechs Covid-19 vaccine production
Novartis has signed an initial agreement to support the production of Pfizer and BioNTech’s Covid-19 vaccine by leveraging its manufacturing capacity and capabilities to fight the Covid-19 pandemic.
Novartis has signed an initial agreement to support the production of Pfizer...
News
Serum Institute of India plans clinical trials of second Covid-19 vaccine
Serum Institute of India (SII) has announced plans to conduct clinical trials of another Covid-19 vaccine in the country, with hopes to launch it in June.
Covovax will be the second vaccine from SII (the first being Covishield) developed by...
Clinical Trials
Aizon Launches GxP AI Bioreactor Application for the Pharma Industry to Scale Manufacturing & Quality
Aizon launches its Bioreactor Application, the pharma industry’s first predictive analysis and deep knowledge management application. The Aizon Bioreactor Application adds the bioreactor process to the “Smart Manufacturing” transformation that is accelerating across the Pharma and Biotech industry. Aizon...
Clinical Trials
Rigel Awarded $16.5 Million from U.S. Department of Defense for Phase 3 Clinical Trial of Fostamatinib in COVID-19 Patients
Rigel Pharmaceuticals, Inc. announced it has been awarded $16.5 million by the U.S. Department of Defense's (DOD) Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) to support Rigel's ongoing Phase 3 clinical trial to evaluate...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.